By staff writers

December 8, 2016 -- The U.S. Food and Drug Administration (FDA) has cleared microultrasound technology developer Exact Imaging's ExactVu system.

ExactVu is designed for prostate imaging and biopsy guidance. It offers resolution down to 70 microns and operates on a frequency of 29 MHz, according to the firm.

Exact Imaging received the CE Mark for the device in November.

Copyright © 2016

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking